UMIN ID: UMIN000002169
Registered date:07/07/2009
Safety and efficacy of 3 DMARDs for 2 years of treatment in patients with early rheumatoid arthritis
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Rheumatoid Arthritis |
| Date of first enrollment | 2009/07/01 |
| Target sample size | 60 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Salazosulfapyridine Bucillamine |
Outcome(s)
| Primary Outcome | DAS |
|---|---|
| Secondary Outcome | remisshion |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 80years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Autoimmuno disease without RA |
Related Information
| Primary Sponsor | Higashi-Hiroshima Memorial Hospital |
|---|---|
| Secondary Sponsor | none |
| Source(s) of Monetary Support | Santen Pharmaceutical Co., Ltd.,none |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Mitsuhiro Iwahasi |
| Address | 2214, Yosiyuki, saijo-chou, Higasihirosima-city, Hirosima, 739-0002, Japan Japan |
| Telephone | 082-423-6661 |
| Affiliation | Director RA center |
| scientific contact | |
| Name | Seizo Yamana |
| Address | 2214, Yosiyuki, saijo-chou, Higasihirosima-city, Hirosima, 739-0002, Japan Japan |
| Telephone | 082-423-6661 |
| Affiliation | Higashi-Hiroshima Memorial Hospital Director |